207 related articles for article (PubMed ID: 23046638)
1. Incidental finding of an endobronchial tumor by 18F-FDG PET/CT.
Navales I; Garcia JR; Alvarez-Moro FJ; Navarro A; Escobar I; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):271-2. PubMed ID: 23046638
[No Abstract] [Full Text] [Related]
2. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
3. [Incidental detection of Paget disease on ¹⁸F-FDG PET/CT scan in a patient with rectal cancer].
Mena LM; Hernández AC; Gallego M; Martínez T; Contreras JF
Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):117-8. PubMed ID: 23177337
[No Abstract] [Full Text] [Related]
4. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer.
Yu HM; Liu YF; Hou M; Liu J; Li XN; Yu JM
Eur J Radiol; 2009 Oct; 72(1):104-13. PubMed ID: 18640802
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate.
Sahiner I; Akkas BE; Ucmak Vural G
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):193-5. PubMed ID: 23218515
[TBL] [Abstract][Full Text] [Related]
7. Autocontouring and manual contouring: which is the better method for target delineation using 18F-FDG PET/CT in non-small cell lung cancer?
Wu K; Ung YC; Hwang D; Tsao MS; Darling G; Maziak DE; Tirona R; Mah K; Wong CS
J Nucl Med; 2010 Oct; 51(10):1517-23. PubMed ID: 20847172
[TBL] [Abstract][Full Text] [Related]
8. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
9. 18F FDG PET/CT in a child with gliomatosis cerebri.
Sürücü E; Mutafoğlu K; Ince D; Cakmakçı H; Demiral A; Polack BD
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):273-4. PubMed ID: 23122744
[No Abstract] [Full Text] [Related]
10. Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients.
Takenaka D; Ohno Y; Koyama H; Nogami M; Onishi Y; Matsumoto K; Matsumoto S; Yoshikawa T; Sugimura K
Eur J Radiol; 2010 Jun; 74(3):458-64. PubMed ID: 19398291
[TBL] [Abstract][Full Text] [Related]
11. Multiple leiomyosarcoma foci in 18F-FDG PET-CT.
Sürücü E; Aslan M; Karahan P; Durak H
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):269-70. PubMed ID: 23122743
[No Abstract] [Full Text] [Related]
12. F-18 FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation.
Iagaru A; Mari C; Segall G
Clin Nucl Med; 2006 May; 31(5):279-80. PubMed ID: 16622337
[No Abstract] [Full Text] [Related]
13. Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT.
Kasai T; Motoori K; Horikoshi T; Uchiyama K; Yasufuku K; Takiguchi Y; Takahashi F; Kuniyasu Y; Ito H
Eur J Radiol; 2010 Aug; 75(2):143-6. PubMed ID: 19446975
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.
Zhang HQ; Yu JM; Meng X; Yue JB; Feng R; Ma L
Eur J Radiol; 2011 Jan; 77(1):92-6. PubMed ID: 19695804
[TBL] [Abstract][Full Text] [Related]
15. Inferior mesenteric venous thrombosis and 18F-FDG PET/CT.
Peiró V; Alonso Farto JC; García Poza J; Alfonso JM
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):55-6. PubMed ID: 23177347
[No Abstract] [Full Text] [Related]
16. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
17. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
Nestle U; Kremp S; Grosu AL
Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
[TBL] [Abstract][Full Text] [Related]
18. Detection of vascular malformation mimicking lung mass in 18F-FDG PET/CT.
Orsal E; Seven B; Kursad Ayan A; Sahin A; Maman A
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):400-1. PubMed ID: 23669272
[No Abstract] [Full Text] [Related]
19. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
20. Pretherapy and posttherapy 18F-FDG PET/CT in isolated nasoseptal diffuse large B-cell lymphoma.
Asa S; Aliyev A; Yılmaz S; Erkan ME; Sager S; Halac M
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):62-3. PubMed ID: 23177348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
